Medtronic Partners with Cornerstone Robotics to Enhance Access to Robotic Surgery Worldwide

Medtronic and Cornerstone Robotics Team Up to Transform Surgical Access

In a move that could redefine the landscape of surgical care, Medtronic, a prominent player in healthcare technology, has entered into a strategic partnership with Cornerstone Robotics. This collaboration aims to enhance global access to robotic-assisted surgery, which is rapidly evolving as a choice for minimally invasive treatment options worldwide.

Expanding the Horizon of Robotic Surgery

The partnership marks a significant investment of approximately $700 million, which includes the rights for Medtronic to distribute Cornerstone Robotics' innovative Sentire™ surgical system in specified markets beyond the United States. With this investment, Medtronic is poised to bolster its existing Hugo™ robotic-assisted surgery (RAS) system by incorporating Sentire into its offerings, effectively creating a unique portfolio of surgical solutions designed to meet varied healthcare demands globally.

Currently, the adoption of robotic-assisted surgery remains relatively low, with global usage still in single digits. This reality provides a vast opportunity for Medtronic and Cornerstone Robotics to improve access to advanced surgical care, enhancing options for both patients and healthcare systems. The combination of the two platforms is expected to cater to an array of surgical needs, ensuring that surgeons have flexible tools at their disposal to improve patient outcomes.

Matt Anderson, Medtronic’s Senior Vice President and President of Surgical, emphasized the importance of this collaboration when he said, "Our strategy is focused on driving the next generation of minimally invasive surgery, one of our biggest growth opportunities. With Sentire complementing the Hugo RAS system, we can offer more access and flexibility to meet diverse clinical and operational needs."

Building upon a Successful Foundation

This partnership builds on the momentum that Medtronic's Hugo RAS system has gathered, which is now operational in over 35 countries and has received FDA clearance in the United States within the past year. The system is currently experiencing impressive growth, outpacing the overall market for robotic surgeries, with procedures projected to surpass 50,000 by the end of Medtronic’s fiscal year.

Medtronic is committed to continuous innovation and improvement of the Hugo RAS system, which includes ongoing enhancements in software, real-time artificial intelligence, integrated tools, and an expanded range of clinical indications. This modern, modular platform is tailored for various soft-tissue surgical procedures, highlighting its versatility in the operating room.

Introducing the Sentire Surgical System

Cornerstone Robotics' Sentire surgical system is distinct and designed with an immersive console and dual-console capability that aligns with diverse surgeon preferences. Having successfully completed extensive multi-specialty clinical trials, Sentire has gained CE Mark approval for its use in various minimally invasive surgical disciplines, including general, gynecologic, thoracic, and urologic procedures. Furthermore, it has received market approval in China and Singapore, underscoring its growing global footprint.

Samuel Au, the founder and CEO of Cornerstone Robotics, stated, "We are confident that this partnership will benefit physicians and patients as we work to broaden access across this dynamic market. We remain steadfast in our commitment to innovation and clinical excellence."

A Strategic Move Toward Global Health Improvement

Both companies share a vision to improve patient outcomes and expand the availability of advanced surgical technologies through their extended partnership. The investment and collaboration reinforce Medtronic's commitment to enhancing surgical access on a global scale, proving to be another pivotal step in their ongoing quest to integrate innovative solutions into healthcare.

With the surgery landscape constantly evolving, partnerships like that of Medtronic and Cornerstone Robotics signify a robust effort to drive forward the capabilities of robotic-assisted surgery, ensuring healthcare systems are well-equipped for the challenges of tomorrow.

Conclusion

As Medtronic and Cornerstone Robotics embark on this strategic partnership, the implications for both surgical innovation and accessibility are profound. By integrating their resources and expertise, these two companies are not only addressing current market needs but are also shaping the future of surgical procedures, paving the way for better healthcare solutions worldwide.